Last Modified: April 1, 2007
Conference Dates: April 26, 2007
Conference Location: Mandalay Bay North Convention Center - Las Vegas, NV
Sponsoring Group: MMRF, PIM and Curatio CME Institute
Conference Web Page URL: http://events.axis-healthcare.com/profile/web/index.cfm?PKwebID=0x543579a9
Topics Covered: This symposium seeks to provide oncology nurses with a clinically focused overview of current and emerging therapeutic options, as well as strategies to control symptoms and side effects for patients with newly diagnosed or relapsed/refractory multiple myeloma.
Conference Objectives: Provide an overview of current and emerging therapeutic options and direction on the control of symptoms and side effects in patients with newly diagnosed or relapsed/refractory multiple myeloma.
Who Should Attend: Oncology Nurses
Registration Information: To register, visit http://events.axis-healthcare.com/profile/form/index.cfm?PKformID=0x175193ab9
Conference Fees: Free
Continuing Education: Yes
Miscellany: This educational activity for 1.5 contact hours is provided by Postgraduate Institute for Medicine (PIM).
Mar 9, 2010 - The presence and number of focal lesions detected by whole-body magnetic resonance imaging strongly predicts the conversion of asymptomatic multiple myeloma to symptomatic disease, according to a study published online Feb. 22 in the Journal of Clinical Oncology. In a related study in the same issue, researchers report that survival after treatment for multiple myeloma decreases with age.
May 3, 2012